[HTML][HTML] Recent advances in the diagnosis and treatment of acute myocardial infarction

K Reddy, A Khaliq, RJ Henning - World journal of cardiology, 2015 - ncbi.nlm.nih.gov
Abstract The Third Universal Definition of Myocardial Infarction (MI) requires cardiac
myocyte necrosis with an increase and/or a decrease in a patient's plasma of cardiac …

“No-reflow” phenomenon: A contemporary review

G Annibali, I Scrocca, TC Aranzulla, E Meliga… - Journal of clinical …, 2022 - mdpi.com
Primary percutaneous angioplasty (pPCI), represents the reperfusion strategy of choice for
patients with STEMI according to current international guidelines of the European Society of …

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart …

PT O'Gara, FG Kushner, DD Ascheim, DE Casey… - Journal of the American …, 2013 - jacc.org
1.1. Methodology and Evidence Review The recommendations listed in this document are,
whenever possible, evidence based. The current document constitutes a full revision and …

Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial

GW Stone, A Maehara, B Witzenbichler, J Godlewski… - Jama, 2012 - jamanetwork.com
Context Thrombus embolization during percutaneous coronary intervention (PCI) in ST-
segment elevation myocardial infarction (STEMI) is common and results in suboptimal …

Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a …

H Thiele, J Wöhrle, R Hambrecht, H Rittger… - The Lancet, 2012 - thelancet.com
Background Intracoronary administration of an abciximab bolus during a primary
percutaneous coronary intervention results in a high local drug concentration, improved …

Pathophysiology, diagnosis, and management of the no-reflow phenomenon

J Allencherril, H Jneid, D Atar, M Alam, G Levine… - … Drugs and Therapy, 2019 - Springer
Successful reperfusion of an infarct-related coronary artery by primary percutaneous
intervention or fibrinolysis during acute ST-elevation myocardial infarction (STEMI) does not …

Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment …

A Kurtul, M Yarlioglues, SN Murat, G Ergun… - The American journal of …, 2014 - Elsevier
Impaired coronary flow after primary percutaneous coronary intervention (PPCI) is
associated with short-and long-term morbidity and mortality in patients with acute ST …

Reperfusion strategies in acute coronary syndromes

A Bagai, GD Dangas, GW Stone… - Circulation Research, 2014 - Am Heart Assoc
The appropriate timing of angiography to facilitate revascularization is essential to optimize
outcomes in patents with ST-segment–elevation myocardial infarction and non–ST-segment …

[PDF][PDF] 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction

JA de Lemos, SM Ettinger - Journal of the American College of …, 2013 - academia.edu
1.1. Methodology and Evidence Review The recommendations listed in this document are,
whenever possible, evidence based. The current document constitutes a full revision and …

Usefulness of the SYNTAX score to predict “no reflow” in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial …

M Magro, ST Nauta, C Simsek, E Boersma… - The American journal of …, 2012 - Elsevier
The no-reflow phenomenon has been shown to have a significant effect on clinical
outcomes in patients with acute ST-segment elevation myocardial infarction. Angiographic …